[Research Report] the direct-to-consumer genetic testing market size was valued at US$ 1,715.84 million in 2022 and is expected to reach US$ 7,191.68 million by 2030. It is estimated to register a CAGR of 19.6% from 2022 to 2030.
Market Insights and Analyst View:
Direct-to-consumer genetic testing is a rapidly growing segment in the healthcare industry. Attractive media and advertisements, such as the internet, printed layouts, radio, and television, widely lead to the popularity of direct-to-consumer genetics. In addition, the easy availability of test kits through stores and e-commerce platforms is leading the market's growth. Also, the entrance of many consumer genetic testing companies into the market enables direct-to-consumer genetic testing market growth.
The growing awareness about direct-to-consumer genetic testing is creating opportunities for the growth of direct-to-consumer genetic testing market size. Further, the growing advancements in technology to provide genetic testing for homecare settings increases the demand for over-the-counter genetic testing. The increase in product launches is fueling the demand for advanced genetic testing kits. For instance, in July 2023, Quest Diagnostics launched a consumer-focused genetic test, Genetic Insights. The kit will utilize saliva to examine 36 genes and help analyze 24 potential inheritable conditions.
Growth Drivers and Challenges:
The global burden of genetic diseases is increasing. According to an article published in 2022 by The Guardian, ~5% of the world's population is affected by sickle cell disease, and approximately 300,000 babies are born with sickle cell anemia worldwide every year. The World Health Organization estimates that 10 in 1,000 people are affected. This means 70 to 80 million people worldwide live with one of these diseases. In 2020, the Online Mendelian Inheritance in Man (OMIM) resource listed 6,594 diseases with known molecular genetic defects, comprising 4,225 genes. This number is continuously increasing to approximately 50–60 new genetic diseases annually, as per the Orphanet and OMIM databases. The NIH Undiagnosed Diseases Program and Network and the International Rare Diseases Research Consortium are a few initiatives further accelerating the discovery rate of novel genetic diseases.
According to the CDC, 1 in 500 African Americans are diagnosed with sickle cell disease, and the autosomal recessive mutation is carried by 1 in 12 African Americans. In 2021, according to the Sickle Cell Society, almost 15,000 people in the suffered from sickle cell disease, and nearly 270 babies were born with sickle cell disease each year in the UK. Furthermore, developing countries such as India are most affected by the disease. According to ETHealthWorld, in India, there are an estimated 18 million sickle cell trait (SCT) patients, and ~1.4 million patients have sickle cell disease (SCD). A dramatic increase in genetic disorders such as cystic fibrosis, sickle cell anemia, Alzheimer's disease (AD), and some cancers is expected to increase the demand for DTC genetic testing. According to the Alzheimer's Association, by 2023, nearly 6.7 million Americans aged 65 will have Alzheimer's-related dementia. Furthermore, the number is expected to rise to 13.8 million by 2060, with no breakthrough that either slows or cures the disease.
The incidence of genetic disorders in newborns is also increasing. According to the World Health Organization 2022 report, neural tube defects, Down syndrome, and heart defects are a few common severe congenital disabilities. According to the CDC, in the US, Down syndrome affects nearly 6,000 newborn babies yearly, one in 700 babies; and in India, every year, nearly 23,000 to 29,000 children, one in 831, have Down syndrome. According to the report titled "Neural tube defects: Different types and a brief overview of the neurulation process and its clinical implications," published in the Journal of Family Medicine and Primary Care in 2021, more than 300,000 cases of Neural tube defects (NTDs) are recorded worldwide each year. These factors are encouraging the introduction of genetic testing for inherited diseases.
Therefore, the increasing incidence of genetic disorders worldwide boosts the direct-to-consumer genetic testing market growth.
On the other hand, high costs and privacy concerns associated with direct-to-consumer genetic testing can hamper the market growth. Many manufacturers focus on product innovation and integrating next-generation technologies to introduce high-quality DTC testing, resulting in higher product prices. For example, according to MedlinePlus, depending on the test's complexity and the disease's severity, the cost of DTC genetic testing varies from US$ 100 to US$ 3,000. Therefore, the demand for genetic services in underdeveloped and developing regions can decline due to affordability problems.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Direct-to-Consumer Genetic Testing Market: Strategic Insights
Market Size Value in US$ 1,715.84 million in 2022 Market Size Value by US$ 7,191.68 million by 2030 Growth rate CAGR of 19.6% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Direct-to-Consumer Genetic Testing Market: Strategic Insights
| Market Size Value in | US$ 1,715.84 million in 2022 |
| Market Size Value by | US$ 7,191.68 million by 2030 |
| Growth rate | CAGR of 19.6% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The direct-to-consumer genetic testing market is segmented into test type, technology, and distribution channel. Based on test type, the market is subsegmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. Based on technology, the market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. In terms of distribution channel, the market is categorized into online and offline. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
Based on test type, the ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register the highest CAGR during 2022–2030.
Ancestry testing, also known as genealogical or genetic genealogy testing, is a prominent component of direct-to-consumer (DTC) genetic testing services. These tests aim to provide individuals with insights into their genetic heritage, ancestral origins, and connections to distant relatives. Ancestry tests analyze specific regions of an individual's DNA to estimate their ancestral origins. These regions are known as genetic markers, and they are compared to databases of DNA samples from various populations around the world. Ancestry tests typically provide ethnicity or ancestral origin estimates, breaking down a person's genetic heritage into percentages or regions. For example, a test might indicate that someone has 30% European, 40% African, and 30% Asian ancestry. Some ancestry tests may provide information about ancient migration patterns and the likely routes one's ancestors took as they moved across the globe.
Some companies offer specialized tests for tracing paternal (Y-DNA) and maternal (mitochondrial or mtDNA) lineages. These tests can provide insights into one's direct maternal and paternal ancestry.
Advanced ancestry tests can provide insights into deep ancestry, such as haplogroups, which are ancient genetic markers shared by groups of people with a common ancestor thousands of years ago. Many DTC genetic testing companies offer online tools and platforms for building family trees, connecting with relatives, and exploring one's genealogy.
Ancestry testing is often pursued for recreational and educational purposes. It can be an exciting way to learn about one's heritage and connect with a broader community of genealogists and DNA enthusiasts.
Direct-to-Consumer Genetic Testing Market, by Test Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on distribution channel, the online segment held a larger market share in 2022, and it is anticipated to register a higher CAGR of 19.8% in the market during 2022–2030.
Regional Analysis:
Based on geography, the direct-to-consumer genetic testing market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The presence of large healthcare businesses and the growing use of direct-to-consumer genetic testing will continue to offer opportunities for market growth in the region during the forecast period. Further, the rising support from governments to address growing concerns about genetic diseases favors North America's direct-to-consumer genetic testing market progress. US held the largest market share in the North America direct-to-consumer genetic testing market. The FDA approved 23andMe's DTC genetic test in 2022 for a hereditary prostate cancer marker. Direct-to-consumer genetic testing has been gaining significant popularity in the US. According to the US National Institutes of Health (NIH), DTC genetic tests are marketed directly to consumers via television, print advertising, or the Internet. Thus, the increasing prevalence of genetic disorders, coupled with the rising adoption of advanced gene therapies to treat chronic diseases, drives the market in the US.
Moreover, Asia Pacific region is expected to witness fastest growth rate during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.
Industry Developments and Future Opportunities:
Various initiatives by key direct-to-consumer genetic testing companies in the market are listed below:
- In September 2023, 23andMe Holding Co. and Sickle Cell 101 joined forces to expand awareness of people's sickle cell carrier status. The collaboration will include DNA testing and access to 23andMe's Health + Ancestry Service for up to 1,000 eligible participants, and 23andMe will be providing monetary support to Sickle Cell 101 to support this effort.
- In November 2022, Myriad Genetics, Inc. acquired Gateway Genomics, LLC, a personal genomics company and developer of consumer genetic tests, including the No. 1 selling SneakPeek Early Gender DNA Test. SneakPeek reveals a baby's gender at six weeks into pregnancy -- the only at-home test avilable for earliest method.
- In August 2020, Ancestry launched the Ancestry Health powered by Next Generation Sequencing, which helps in understanding important developments in consumers' access to their health. The advanced testing technology behind Ancestry Health provides a complete and expanded set of health conditions, such as heart disease, breast cancer, colon cancer, and blood disorders, through genetic screening.
Competitive Landscape and Key Companies:
A few prominent DTC genetic testing companies operating in the market are Genesis Healthcare Co; Ancestry Genomics Inc; Color Health Inc; Helix Inc; Myriad Genetics, Inc; Living DNA Ltd; 23andMe Inc; Genetic Technologies Ltd; Gene By Gene Ltd, and Full Genomes Corp Inc. These companies focus on organic and inorganic strategies to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type, Technology, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
direct-to-consumer genetic testing is also known as direct-access genetic testing, at-home genetic testing, DTC genetic testing, home DNA testing, and Ancestry testing, also known as genealogy testing. DTC genetic testing differs from conventional and is performed in a homecare setting. Thus, the genetic test kits are sold as OTC products and can be purchased online. During the process of direct-to-consumer genetic testing, it allows people to access their genetic information by avoiding a healthcare provider or health insurance company.
The market's growth is attributed to the growing incidence of genetic disorders, and increasing awareness about the potential benefits of genetic testing drives the market. On the other hand, the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.
The direct-to-consumer genetic testing market majorly consists of players such as Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 7andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.
The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030. The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.
Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and was anticipated to register the highest CAGR during 2022–2030.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Direct-To-Consumer Genetic Testing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Direct-To-Consumer Genetic Testing Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Incidence of Genetic Disorders
5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
5.2 Market Restraints
5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
5.3 Market Opportunities
5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
5.4 Future Trends
5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
5.5 Impact Analysis
6. Direct-To-Consumer Genetic Testing Market - Global Market Analysis
6.1 Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 – 2030
7. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Ancestry Testing
7.3.1 Overview
7.3.2 Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Nutrigenomics Testing
7.4.1 Overview
7.4.2 Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Predictive Testing
7.5.1 Overview
7.5.2 Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Carrier Testing
7.6.1 Overview
7.6.2 Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Whole Genome Sequencing
8.3.1 Overview
8.3.2 Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Single Nucleotide Polymorphism Chips
8.4.1 Overview
8.4.2 Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Targeted Analysis
8.5.1 Overview
8.5.2 Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Online Platform
9.3.1 Overview
9.3.2 Online Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Offline Platform
9.4.1 Overview
9.4.2 Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Direct-To-Consumer Genetic Testing Market
10.1.1 Overview
10.1.2 North America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.2.2 North America: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3 North America: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3 North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.1.3.1 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.2 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 US: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.2.2 US: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.2.3 US: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.3 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.4 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.4.1 Canada: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.4.2 Canada: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.4.3 Canada: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.5 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.6 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.6.1 Mexico: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.6.2 Mexico: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.6.3 Mexico: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Direct-To-Consumer Genetic Testing Market
10.2.1 Overview
10.2.2 Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.2.2 Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.2.3.1 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.2 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Germany: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.2.2 Germany: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.2.3 Germany: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.3 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.4 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 UK: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.4.2 UK: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.4.3 UK: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.5 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.6 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 France: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.6.2 France: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.6.3 France: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.7 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.8 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.8.1 Italy: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.8.2 Italy: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.8.3 Italy: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.9 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.10 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.10.1 Spain: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.10.2 Spain: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.10.3 Spain: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.11 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.12 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.12.1 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.12.2 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.12.3 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market
10.3.1 Overview
10.3.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.2.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.2.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.3.3.1 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.2 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 China: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.2.2 China: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.2.3 China: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.3 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.4 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Japan: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.4.2 Japan: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.4.3 Japan: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.5 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.6 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 India: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.6.2 India: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.6.3 India: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.7 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.8 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.8.1 Australia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.8.2 Australia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.8.3 Australia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.9 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.10 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.10.1 South Korea: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.10.2 South Korea: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.10.3 South Korea: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.11 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.12 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.12.1 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.12.2 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.12.3 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Direct-To-Consumer Genetic Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.2.1 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.2.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.2.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.4.3.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.2.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.3 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.4 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 South Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.4.2 South Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.4.3 South Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.5 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.6 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.6.1 UAE: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.6.2 UAE: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.6.3 UAE: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.7 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.8 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.8.1 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.8.2 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.8.3 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Direct-To-Consumer Genetic Testing Market
10.5.1 Overview
10.5.2 South & Central America: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.5.2.1 South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.2.2 South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.2.3 South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3 South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
10.5.3.1 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.2 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Brazil: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.2.2 Brazil: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.2.3 Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.3 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.4 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.4.1 Argentina: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.4.2 Argentina: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.4.3 Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.5 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.6 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.6.1 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.6.2 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.6.3 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
11. Direct-To-Consumer Genetic Testing Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Genesis Healthcare Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ancestry Genomics Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Color Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Helix Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Myriad Genetics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Living DNA Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7andMe Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genetic Technologies Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Gene By Gene Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Full Genomes Corp Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Direct-To-Consumer Genetic Testing Market Segmentation
Table 2. North America Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. Europe Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Europe Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Europe Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 23. France Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. France Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. France Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 28. Italy Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 35. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 37. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. China Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. China Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 40. China Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 41. Japan Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Japan Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 43. Japan Direct-To-Consumer Genetic Testing Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)
Table 44. India Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 45. India Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 46. India Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 47. Australia Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 48. Australia Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 49. Australia Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 50. South Korea Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. South Korea Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 52. South Korea Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)
Table 56. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 57. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 58. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 59. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 60. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 61. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 62. South Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 63. South Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 64. South Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 65. UAE Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. UAE Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 67. UAE Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 71. South & Central America Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 72. South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 73. South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 74. Brazil Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 75. Brazil: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 76. Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 77. Argentina Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. Argentina: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 79. Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 80. Rest of South & Central Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 81. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 82. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 83. Organic Developments Done by Companies
Table 84. Inorganic Developments Done by Companies
Table 85. Glossary of Terms, Direct-To-Consumer Genetic Testing Market
List of Figures
Figure 1. Direct-To-Consumer Genetic Testing Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Direct-To-Consumer Genetic Testing Market: Key Industry Dynamics
Figure 4. Direct-To-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
Figure 5. Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Direct-To-Consumer Genetic Testing Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 8. Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 14. Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 19. Hospitals & Clinics: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. North America Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 24. US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. Europe Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 30. Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 37. Asia Pacific Direct-To-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 39. China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 46. Middle East & Africa Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 48. Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. South & Central America: Direct-To-Consumer Genetic Testing Market, By Key Country – Revenue (2022) (US$ Million)
Figure 53. South & Central America: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 54. South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
Figure 55. Brazil: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 56. Argentina: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 57. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
The List of Companies - Direct-to-Consumer Genetic Testing Market
- Genesis Healthcare Co
- Ancestry Genomics Inc.
- Color Health Inc.
- Helix Inc.
- Myriad Genetics, Inc.
- Living DNA Ltd
- 7andMe Inc.
- Genetic Technologies Ltd
- Gene By Gene Ltd
- Full Genomes Corp Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Direct-to-Consumer Genetic Testing Market
Oct 2023
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2023
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2023
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2023
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2023
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2023
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2023
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Oct 2023